1h Free Analyst Time
The Asparagine Market size was estimated at USD 11.81 billion in 2023, USD 12.40 billion in 2024, and is expected to grow at a CAGR of 5.29% to reach USD 16.96 billion by 2030. Speak directly to the analyst to clarify any post sales queries you may have.
Asparagine, an amino acid, plays a fundamental role in the biosynthesis of proteins. It is an essential component required for the development and functioning of the brain and is a precursor to neurotransmitters. The asparagine market spans various industries, including biotechnology, food and beverage, pharmaceuticals, and animal feed, showcasing its broad spectrum of utilizations. Analyzing the market requires insights into its applications, end-uses, market scope, growth opportunity factors, limitations, and potential areas of innovation. Rising health consciousness for dietary supplements and increased investment in R&D in the pharmaceutical industry are driving the market growth.
Ongoing innovations in the food and beverage industry are also propelling the market. Fluctuations in the prices of raw materials and stringent regulations and standards regarding the use of asparagine are restricting market growth. The development of novel pharmaceutical formulations containing asparagine and the rise in precision medicine and targeted therapies are expected to create opportunities in the market.
Regional Insights
The Asparagine market in the Americas is characterized by advanced biotechnology sectors, particularly in North America. The United States produces and consumes Asparagine, predominantly for the pharmaceuticals and food industries. South America's market is emerging, with Brazil showing increasing demand for Asparagine in food additive applications and research. Stringent regulations on North American food additives and clinical nutrition bolster the demand for high-purity Asparagine. The Asia-Pacific, led by China, Japan, and India, has a rapidly expanding asparagine market due to its growing pharmaceutical, food, and beverage industries.China's large-scale manufacturing capabilities make it a significant supplier of Asparagine domestically and globally. The region is witnessing growth in nutrition and health supplement sectors, driving the need for amino acids such as Asparagine. The evolving regulatory landscape and increasing consumer health consciousness further shape the market dynamics. In EMEA, Europe leads with a mature market for Asparagine, particularly within the pharmaceutical and nutraceutical industries. The steadily aging population contributes to the region's significant demand for dietary supplements and parenteral nutrition, which includes Asparagine. The market needs to be developed in the Middle East and Africa but presents potential for growth with rising health awareness and changing dietary habits.
Market Trends by Segment
- Type:Growing demand for Anhydrous asparagine in dry-blending nutritional formulations
- Application: Rising usage of Asparagine for enhancing nutritional value and flavor profiles of products
Industry Insights
- Market Dynamics
- Market Disruption Analysis
- Porter’s Five Forces Analysis
- Value Chain & Critical Path Analysis
- Pricing Analysis
- Technology Analysis
- Patent Analysis
- Trade Analysis
- Regulatory Framework Analysis
- FPNV Positioning Matrix
- Market Share Analysis
- Strategy Analysis and Recommendations
Recent Developments
Jazz Pharmaceuticals Receives European Commission Approval for Enrylaze (a recombinant Erwinia asparaginase or crisantaspase) for the Treatment of Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma
Jazz Pharmaceuticals plc has announced a significant development with the European Commission's approval of Enrylaze (JZP458), a recombinant Erwinia asparaginase, under the brand name Rylaze in the U.S. and Canada. This endorsement authorizes Enrylaze for use within multi-agent chemotherapy treatments for acute lymphoblastic leukemia (ALL) and lymphoblastic lymphoma (LBL) for those aged one month and older who are intolerant and have an inadequate response to E. coli-derived asparaginases.Kaimisi New Material and Bicells to build 2,000 t per year L-asparagine project and 100 t per year GABA project
Shandong Kaimisi New Material Technology Co., Ltd. has announced the successful publication of their Environmental Impact report, approved on October 11 by the Dongying Municipal Ecological Environment Bureau, for a pioneering L-asparagine production project using biofermentation. The project, situated in Dongying City's Economic Development Zone, sees an investment of approximately USD 28.17 million aimed at erecting a state-of-the-art facility capable of yielding 2,000 tons per annum (t/a) of this essential amino acid, known for its extensive applications across the food, medical, and environmental protection industries.Key Company Profiles
The report delves into recent significant developments in the Asparagine Market, highlighting leading vendors and their innovative profiles. These include BioVendor Group, Creative Enzymes, Duchefa Biochemie B.V., Jazz Pharmaceuticals, Inc., LGC Limited, medac GmbH, Merck KGaA, MP Biomedicals, LLC, Porton Biopharma Limited, Taj Pharmaceuticals Ltd., Tokyo Chemical Industry (India) Pvt. Ltd., and VWR International, LLC.This research report offers invaluable insights into various crucial aspects of the Asparagine Market:
- Market Penetration: This section thoroughly overviews the current market landscape, incorporating detailed data from key industry players.
- Market Development: The report examines potential growth prospects in emerging markets and assesses expansion opportunities in mature segments.
- Market Diversification: This includes detailed information on recent product launches, untapped geographic regions, recent industry developments, and strategic investments.
- Competitive Assessment & Intelligence: An in-depth analysis of the competitive landscape is conducted, covering market share, strategic approaches, product range, certifications, regulatory approvals, patent analysis, technology developments, and advancements in the manufacturing capabilities of leading market players.
- Product Development & Innovation: This section offers insights into upcoming technologies, research and development efforts, and notable advancements in product innovation.
Additionally, the report addresses key questions to assist stakeholders in making informed decisions:
- What is the current market size and projected growth?
- Which products, segments, applications, and regions offer promising investment opportunities?
- What are the prevailing technology trends and regulatory frameworks?
- What is the market share and positioning of the leading vendors?
- What revenue sources and strategic opportunities do vendors in the market consider when deciding to enter or exit?
With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.
This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.
Table of Contents
1. Preface
2. Research Methodology
5. Market Insights
6. Asparagine Market, by Type
7. Asparagine Market, by Application
8. Americas Asparagine Market
9. Asia-Pacific Asparagine Market
10. Europe, Middle East & Africa Asparagine Market
11. Competitive Landscape
12. Competitive Portfolio
List of Figures
List of Tables
Companies Mentioned
- BioVendor Group
- Creative Enzymes
- Duchefa Biochemie B.V.
- Jazz Pharmaceuticals, Inc.
- LGC Limited
- medac GmbH
- Merck KGaA
- MP Biomedicals, LLC
- Porton Biopharma Limited
- Taj Pharmaceuticals Ltd.
- Tokyo Chemical Industry (India) Pvt. Ltd.
- VWR International, LLC
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 194 |
| Published | May 2024 |
| Forecast Period | 2024 - 2030 |
| Estimated Market Value ( USD | $ 12.4 Billion |
| Forecasted Market Value ( USD | $ 16.96 Billion |
| Compound Annual Growth Rate | 5.2% |
| Regions Covered | Global |
| No. of Companies Mentioned | 12 |
